Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 placebo-controlled study of RO5093151 and RO5027838 added to metformin in type 2 diabetes
2008-001122-13Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RO5093151 and ro5027838 in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Roche. Primary endpoint: Absolute change in mean daily plasma glucose from baseline to Day 27. Started Nov 2008; status: completed.
02
Drugs
RO5093151ro5027838
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001122-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001122-13.